CharlesGavoty

Partner

Paris + 33.1.56.59.39.39

Connect:

Share

Recognized as a leading lawyer, Charles Gavoty serves clients in the hi-tech, biotech, medtech, and fintech industries in matters relating to capital markets, mergers and acquisitions, venture capital, and private equity. He represents a large number of emerging companies and their managers or investors in transactions ranging from seed to late-stage financing, private and public M&A deals, IPOs, private placements, and rights issues, to corporate structuring and management compensation packages.

Representative of Charles's work is his involvement in Completel's friendly takeover by Altice for $1 billion; the successful defense of Wavecom against Gemalto's hostile bid and the subsequent friendly takeover of Wavecom by Sierra Wireless; the sale of Novexel to AstraZeneca for US$505 million; the sales of Capitain Train, We Are Cloud, MobPartner, Movea, and Ipdia; the IPO of Inside Secure, SuperSonic Imagine, and Tronics; the equity lines of Cellectis, Inside Secure, and Carmat; the convertible bonds (Oceanes) issue of Inside Secure; the last financing rounds of Frichti, Alkemics, and DataBerries; and the investment by Benchmark, NJJ, and Idinvest in Zenly.

Charles's other recent representations of tech/biotech companies include Alkemics, Carmat, Cellectis, Clustree, Criteo, Databerries, Frichti, Inside Secure, Happn, Novexel, Orange, SAP, Slimpay, Stratumn, SuperSonic Imagine, Theranexus, Veolia, and Voltalia, and, on the investors' side, Alven, Benchmark, Bpi, Hi Inov, Idinvest, Index, Kima, Korelya, Kreaxi, NJJ, Omnes Capital, Otium, Partech, Seventure, Sofinnova, Valar, and XAnge.

In 2001, he received the Lavoisier Scholarship awarded by the French Ministry of Foreign Affairs.

Experience

  • Mérieux Equity Partners, Illumina Ventures and Heran Partners invest in Broken String BiosciencesJones Day advised Mérieux Equity Partners, Illumina Ventures and Heran Partners in the Series A financing of Broken String Biosciences, a genomics company based in the UK.
  • Doctrine partners with Summit Partners and Peugeot InvestJones Day advised Forseti (d/b/a Doctrine), a French legaltech developing the leading search engine for precedents, in connection with the acquisition of a controlling stake by Summit Partners and Peugeot Invest.
  • CARMAT completes €31.1 million share capital increaseJones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, with its €31.1 million share capital increase, of which €27.2 million is aimed at specialized investors and €3.9 million for individuals (via the PrimaryBid platform).
  • Seventure leads €12 million Series A funding round of Citalid Cybersécurité SASJones Day advised Seventure Partners as lead investor in the €12 million Series A financing round of Citalid Cybersécurité SAS, a France-based cyber risks management and decision support platform.
  • Valar Ventures leads $20 million Series A financing round of RegateJones Day assisted Valar Ventures as lead investor in the $20 million Series A financing of Regate, a French startup which has built a modern software-as-a-service product that integrates directly with existing accounting stack and connects with corporate bank accounts.
  • USERCUBE acquired by NetwrixJones Day advised the shareholders of USERCUBE in its sale to Netwrix.
  • Ring invests €6 million in LeHibouJones Day advised Ring Capital in the €6 million financing of LeHibou, an intermediation platform between IT freelancers and large companies.
  • Seventure leads €7 million Series A financing round of JolimoiJones Day advised Seventure Partners as lead investor in the €7 million Series A financing round of Jolimoi, a French start-up company engaged in the business of direct and e-commerce sale of multi-brand beauty and lifestyle products using social selling and the development of self-service (SaaS) technological solutions for clients using social selling in the beauty domain.
  • Kalray acquires Arcapix Holdings Ltd.Jones Day advised Kalray in the acquisition of Arcapix Holdings Ltd, a UK headquartered company that offers high-performance storage and data management solutions for intensive and critical data.
  • CARMAT completes €40.5 million share capital increaseJones Day represented CARMAT SA, the designer and developer of the world's most advanced total artificial heart, aiming to provide a therapeutic alternative to people suffering from end-stage biventricular heart failure, with its €40.5 million share capital increase, of which €36.5 million is aimed at specialized and strategic investors and €4.1 million for individuals (via the PrimaryBid platform).
  • Partech, Eurazeo, and Hi Inov invest in Platform.shJones Day advised Partech, Eurazeo, and Hi Inov in the $140 million financing of Platform.sh along with new investors (Digital Growth Fund II and Revaia Growth I).
  • Quadrant Management participates in $45 million Series C financing round of WandercraftJones Day advised Quadrant Management in connection with its participation in a $45 million Series C financing round of Wandercraft, a leading healthtech company in dynamic robotic and exoskeleton technology.
  • Back Market raises $510 million in Series E roundJones Day advised Back Market, a French company specialized in the development and exploitation of an online marketplace dedicated to refurbished products, in connection with its $510 million Series E round of financing led by Sprints Capital with the support of existing investors Eurazeo, Aglaé Ventures, General Atlantic and Generation Investment Management.
  • Valar Ventures and Alven Capital participate in Series D financing round of QontoJones Day assisted Valar Ventures and Alven Capital as co-investors in connection with the €486 million Series D round of financing of Qonto, a business banking platform.
  • Ankorstore raises €250 million in Series C financing roundJones Day advised Ankorstore, a French company developing and operating marketplaces whose purpose is to connect brands and designers with professionals, notably through digital platforms, in connection with its €250 million Series C round of financing led by BOND and Tiger Global.
  • Eight Roads leads $110 million Series B financing round of LeocareJones Day assisted Eight Roads as lead investor in the $110 million Series B financing round of Leocare, the first multiservice neo-insurance in France (home, car, motorcycle, and smartphone).
  • Mérieux Equity Partners leads $150 million growth financing of DentalMonitoringJones Day advised Mérieux Equity Partners in leading the $150 million growth financing of DentalMonitoring, a leading AI-based dental software company monitoring the dental and orthodontics fields, thus granting DentalMonitoring a well-deserved unicorn status, as the second French HealthTech company reaching this type of valuation.
  • TreeFrog Therapeutics raises €64 million in Series B financing roundJones Day represented TreeFrog Therapeutics, a privately held French-based biotech startup focused on developing safe and affordable stem cell-derived cell therapies for millions of patients, in connection with its €64 million Series B financing round led by Bpifrance Large Venture and joined by Leonard Green & Partners L.P., Bristol Myers Squibb, and XAnge.
  • Modjo raises €7 million in Series A roundJones Day advised Modjo in its €7 million Series A financing round with participation from Daphni fund, business angels, and the Aglaé Ventures fund
  • Elephant leads $40 million Series B financing round of DidomiJones Day represented Elephant as a lead investor with Breega in the $40 million Series B financing of Didomi, a Paris-based consent and preference management platform for collecting and leveraging user consents and preferences for businesses.
    • View All

    Additional Publications

    • June 28, 2004
      Vers une extension de l'obligation de renégocation en matière contractuelle ?, Petites Affiches
    • November 17, 2003
      La loi de securite financiere: une loi d'insecurite juridique, Option Finance
    • August - September 2001
      L'absorption par une societe par actions simplifiee exige-t-elle le consentement unaime des associes de la sciete aborbee? Bulletin Joly Societes

    Speaking Engagements

    • January 29, 2013
      Le Private Equity : où en sommes-nous ?
    • May 2007
      Strategic Negotiations, panelist, INSEAD
    • Annually 2005-2013
      The Management Package, ESSEC Business School

    Before sending, please note:

    Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.